|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
4/29/2010 9:41:40 AM
SAN MATEO, Calif.--(BUSINESS WIRE)--Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced today that the company was selected and is scheduled to present at the 2010 BIO Business Forum during the BIO International Convention in Chicago (May 3-6, 2010). Nuon will provide a corporate overview including an update on its phase 2 program in rheumatoid arthritis (RA) and progress with advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. The presentation will be held on Thursday, May 6, 2010 at 10:45 AM Central time in Room 2 of McCormick Place.
|
|
|
|
|
|
|
|
|
|
|